MiMedx Group, Inc (MDXG): Price and Financial Metrics

MiMedx Group, Inc (MDXG): $7.16

0.18 (+2.58%)

POWR Rating

Component Grades








MDXG Price/Volume Stats

Current price $7.16 52-week high $9.27
Prev. close $6.98 52-week low $5.51
Day low $7.02 Volume 562,100
Day high $7.32 Avg. volume 764,688
50-day MA $7.07 Dividend yield N/A
200-day MA $7.51 Market Cap 1.06B

MDXG Stock Price Chart Interactive Chart >

MiMedx Group, Inc (MDXG) Company Bio

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue.

MDXG Latest News Stream

Event/Time News Detail
Loading, please wait...

MDXG Latest Social Stream

Loading social stream, please wait...

View Full MDXG Social Stream

Latest MDXG News From Around the Web

Below are the latest news stories about MIMEDX GROUP INC that investors may wish to consider to help them evaluate MDXG as an investment opportunity.

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

MARIETTA, Ga., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that its outstanding 95,000 shares of Series B Convertible Preferred Stock (the “Preferred Stock”), together with any accrued dividends, were automatically converted into shares of the Company’s Common Stock on December 22, 2023, in accordance with the Preferred Stock terms set forth in the Company’s Articles of Incorporation. As a result of this conversion, approximatel

Yahoo | December 28, 2023

Is MiMedx Group, Inc. (NASDAQ:MDXG) Trading At A 50% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, MiMedx Group fair value estimate is US$17.71 MiMedx Group's...

Yahoo | December 15, 2023

MIMEDX to Participate in Upcoming Investor Conferences

MARIETTA, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Craig-Hallum Capital Group 14th Annual Alpha Select Conference Thursday, November 16, 2023Sheraton New York Times Square Hotel811 7th Avenue, W 53rd St New York, NY Mizuho Medical Device & Healthcare Services Summit 2023Wednesday, December 6, 2023Sofitel New York45 W 44th StNew

Yahoo | November 13, 2023

MIMEDX to Highlight Published Data at SAWC Fall

Company Will Sponsor Lunch Symposium on November 3, 2023MARIETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it will sponsor an Innovation Theater lunch symposium at the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place November 2-5 in Las Vegas, NV. In addition, the Company will participate in the conference’s exhibition at booth number 511. In the session, Drs. Mouawad, Tettelbach, and Wahab will review r

Yahoo | November 2, 2023

Loss-Making MiMedx Group, Inc. (NASDAQ:MDXG) Set To Breakeven

MiMedx Group, Inc. ( NASDAQ:MDXG ) is possibly approaching a major achievement in its business, so we would like to...

Yahoo | November 2, 2023

Read More 'MDXG' Stories Here

MDXG Price Returns

1-mo -9.14%
3-mo -9.14%
6-mo -20.09%
1-year 25.39%
3-year 27.97%
5-year 194.65%
YTD -18.36%
2023 215.47%
2022 -53.97%
2021 33.04%
2020 19.79%
2019 323.46%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!